Grifolsbarcelona traded at $11.97 this Tuesday July 5th, decreasing $0.52 or 4.16 percent since the previous trading session. Looking back, over the last four weeks, Grifolsbarcelona lost 6.41 percent. Over the last 12 months, its price fell by 30.16 percent. Looking ahead, we forecast Grifolsbarcelona to be priced at 12.08 by the end of this quarter and at 10.91 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
Daily Change

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Grifolsbarcelona 11.33 -0.64 -5.35% -33.90%
GlaxoSmithKline 1,791.00 4.40 0.25% 24.63%
Ziopharm Oncology 1.19 -0.11 -8.46% -52.96%

Indexes Price Day Year
USND 11322 194.39 1.75% -22.79%

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.